Clinical Trials Browser

Carcinoma, Hepatocellular × Immune Checkpoint Inhibitors × 90 days × Clear all

Carcinoma, Hepatocellular

NCT07405086 2026-02-12

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

DermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis

NCT05166239 2026-01-23

HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT

Phase 2 Completed

66 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

Clinical Trials

HAIC Plus Lenva and PD-1 for Advanced HCC With Macrovascular or Biliary Invasion

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT